Yuta Okamoto

Learn More
Obtaining an antibody capable of destroying a targeted protein is the eventual goal in developing superior catalytic antibody. We established a monoclonal antibody recognizing a highly conserved sequence, RGPDRPEGIEEEGGERDRD, of gp41 of the HIV-1 envelope. The obtained antibody reacted with gp41 and gp160 of HIV-1. The isolated and purified light chain not(More)
Hepatitis B virus (HBV) is the smallest partially double-stranded DNA virus known to infect humans. Worldwide, more than 50% of hepatocellular carcinoma (HCC) cases are related to chronic Hepatitis B. Development of HCC from normal liver cells is characterized by changes in cell surface N-glycans, which can promote the invasive behavior of tumor cells,(More)
The functions of cell surface proteins, such as growth factor receptors and virus/bacteria-entry receptors, can be dynamically regulated by oligosaccharide modifications. In the present study, we investigated the involvement of glycosylation in hepatitis B virus (HBV) entry into hepatoma cells. Infection of oligosaccharide-remodeling hepatoma cells with a(More)
It has become well known that antibodies obtained by immunization with the ground state of peptides can display proteolytic activity. Our antibody light chain produced by immunization with the peptide RGPDRPEGIEEEGGERDRD, a highly conserved sequence in envelope gp41 of HIV-1 showed the ability to cleave this peptide. Moreover, its heavy chain also(More)
  • 1